Compounded and Counterfeit Semaglutide: What the FDA Is Warning About
Shortages pushed patients toward compounded semaglutide. The FDA's latest alert shows why that workaround carries real risk.
Aug 5, 2024

Search
60 stories for“supply chains”
Shortages pushed patients toward compounded semaglutide. The FDA's latest alert shows why that workaround carries real risk.
Aug 5, 2024

More than 500 species of vesper bat turn out to carry two separate sets of antibody heavy chain genes, where every other known mammal has one. The researchers are careful to say this does not fully explain why bats tolerate viruses.
Sep 4, 2026

Saudi-backed medical projects have delivered urgent surgery and nutrition support in Gaza, combining visiting specialist teams with a longer program targeting hundreds of patients.
Aug 3, 2026

Novo Nordisk folded Rybelsus into the Ozempic name in May and put a self-pay price on it. Getting a peptide to survive the stomach is a real achievement, but the tablet is not simply the injection in another form.
Aug 11, 2026

Updated traveler attention around Ebola-affected areas underscores a basic rule: monitor official advice, know the symptoms and seek help without stigmatizing whole countries.
Jul 24, 2026

On 23 and 24 July, an FDA advisory committee looked at seven peptides and recommended that pharmacies be allowed to compound several of them. The vote is not binding, and the evidence gap has not moved.
Aug 11, 2026
